Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14356/3048
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSharma, Saroj-
dc.contributor.authorMarks, Florian-
dc.date.accessioned2026-06-25T05:47:36Z-
dc.date.available2026-06-25T05:47:36Z-
dc.date.issued2025-
dc.identifier.urihttps://hdl.handle.net/20.500.14356/3048-
dc.descriptionApproval NHRCen_US
dc.description.abstractReport Brief: This Report details the entirety of NAPS phase II, conducted under the CAPTURA II AMU/C surveillance strengthening workstream. It provides a comprehensive overview of all survey activities, from their initiation to completion. For clarity and ease of understanding, the report is structures as a timeline, highlighting the following key stages: 1. NAPS II refresher Training 2. Data Collection 3. Survey Findings and Analysisen_US
dc.language.isoen_USen_US
dc.publisherCAPTURA II/TACE, International Vaccine Institute, Seoul, Koreaen_US
dc.titleNational antimicrobal prescription survey report phase II report: AMU/surveilance strengtheningen_US
dc.typeResearch reporten_US
Appears in Collections:Approval Research Report (NHRC)

Files in This Item:
File Description SizeFormat 
RES01246_SHA_2025.pdfDownload Report for Academic Purpose.1.52 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.